FDA Cracks Down on Alternative Cancer Companies

Recently the U.S. Food and Drug Administration (FDA) issued warning letters to natural products companies involved in the sale of alternative "cancer cures." These companies, either by choice or by lack of knowledge were making illegal disease claims on their websites. These warning letters should serve as a wake-up call to not only the companies that received them but to any other company not in full compliance with the Dietary Supplement Health Education Act (DSHEA).

The FDA in conjunction with the Federal Trade Commission (FTC) police this law which has been in effect since 1994. Thought the vast majority of natural products providers have come to understand DSHEA and are in full compliance, those which are not are running a great risk. The FDA has performed product seizures, has levied fines and stopped companies from selling non-compliant products.

Aim & Act, Inc. (www.aim-act.com) as an avid proponent of integrative cancer treatment and alternative medicines, is fully capable of working with companies to quickly and painlessly come into full regulatory compliance. Aim & Act has significant and longstanding competency in the practical application of the Dietary Supplement Health and Education Act (DSHEA). We have the ability to quickly and cheaply review marketing and sales materials for compliance with all applicable FDA and FTC regulations. We can either simply provide a write-up of suggested changes or completely rework your marketing and sales materials using our in-house experts. Additionally, if the utmost in legal protection is required, Aim & Act has a relationship with one of the best DSHEA law firms in the world. We can do an initial review and then provide the materials to that law firm to give a company an exceptionally high level of legal protection in the most cost-effective way.

Aim & Act is different from any other firm in the world because we combine marketing and scientific services for companies in the natural products industry. Our scientific services include clinical trial design and performance including all types of safety and efficacy trials. With a warning letter from non-compliance comes a substantial amount of bad publicity. One of the best ways to combat this and show customers a dedication to their health by performing primary scientific studies on your products. These scientific studies can yield a significant amount of sales points for your products and put your customers at ease.

Now is the time to act. After a warning letter has been posted, it is available for all the world to see, forever. This will lead to a poor reputation and much more in the way of legal liability. It is best to resolve any issues now quietly and privately with Aim & Act.

Call Aim & Act today at 406-585-5593 or visit us online at www.aim-act.com.